Editorial: Diabetic hearts and biguanides-a reply. 1976

N W Rodger

UI MeSH Term Description Entries
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

N W Rodger
September 1976, Canadian Medical Association journal,
N W Rodger
August 1975, Canadian Medical Association journal,
N W Rodger
February 1977, Die Medizinische Welt,
N W Rodger
January 1974, Canadian Medical Association journal,
N W Rodger
August 1999, Journal of clinical anesthesia,
N W Rodger
February 2021, Urology,
N W Rodger
January 2007, Journal of sex & marital therapy,
N W Rodger
September 2002, Ugeskrift for laeger,
Copied contents to your clipboard!